OncoGenex

About:

OncoGenex develops and commercializes innovative therapies for the treatment of a variety of cancers.

Top Investors: H.I.G. Capital, BDC Venture Capital, Bank Of Canada, Working Opportunity Fund, Ventures West

Description:

OncoGenex’ mission is to meet the challenge of treatment resistance through the development and commercialization of first-in-class, innovative therapies that have the potential to redefine treatment outcomes for patients with a variety of cancers.

Total Funding Amount:

$84.3M

Headquarters Location:

Bothell, Washington, United States

Founded Date:

1991-01-01

Founders:

Scott Cormack

Number of Employees:

51-100

Last Funding Date:

2012-03-16

IPO Status:

Delisted

Industries: